Market revenue in 2023 | USD 466.7 million |
Market revenue in 2030 | USD 1,148.2 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Neurostimulation and neuromodulation devices |
Fastest growing segment | Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomaterials, Neurostimulation and Neuromodulation Devices |
Key market players worldwide | Axogen Inc, Stryker Corp, St. Jude Medical, Baxter International Inc, Boston Scientific Corp, Integra Lifesciences Holdings Corp, Medtronic PLC, Polyganics, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nerve repair and regeneration market will help companies and investors design strategic landscapes.
Neurostimulation and neuromodulation devices was the largest segment with a revenue share of 66.02% in 2023. Horizon Databook has segmented the France nerve repair and regeneration market based on biomaterials, neurostimulation and neuromodulation devices covering the revenue growth of each sub-segment from 2018 to 2030.
The nerve repair and regeneration market in France is expected to exhibit steady growth with a CAGR of 13.7% over the forecast period owing to factors such as the increasing prevalence of neurological disorders as well as economic development.
According to the World Mental Health Survey by WHO, France had the highest rate of Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis as of 2017. According to Paris Brain Institute, PD is the second cause of movement disability and affects around 8,000 people every year in France.
Furthermore, according to Fondation de France, one in five people in France is above 60 years, and by the year 2050, the number is expected to be one in three. France is estimated to have the highest incidence of suicide in the European region.
Horizon Databook provides a detailed overview of country-level data and insights on the France nerve repair and regeneration market , including forecasts for subscribers. This country databook contains high-level insights into France nerve repair and regeneration market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account